Chevron Corporation – Consensus Indicates Potential 14.3% Upside

DirectorsTalk Interviews

Chevron Corporation with ticker code (CVX) now have 28 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 210 and 136 with a mean TP of 178.29. Now with the previous closing price of 155.95 this indicates there is a potential upside of 14.3%. The 50 day MA is 152.38 and the 200 day MA is 148.75. The market cap for the company is $305,261m. Find out more information at: https://www.chevron.com

The potential market cap would be $348,990m based on the market concensus.

Chevron Corporation, through its subsidiaries, engages in integrated energy and chemicals operations worldwide. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification associated with liquefied natural gas; transportation of crude oil through pipelines; and transportation, storage, and marketing of natural gas, as well as operates a gas-to-liquids plant. The Downstream segment engages in refining crude oil into petroleum products; marketing crude oil, refined products, and lubricants; manufacturing and marketing of renewable fuels; transporting crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car; and manufacturing and marketing of commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives. It is also involved in the cash management and debt financing activities; insurance operations; real estate activities; and technology businesses. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is based in San Ramon, California.

Share on:

Latest Company News

EDX Medical launches BC95 bowel cancer testing service in the UK

EDX Medical Group has announced the UK launch of its BC95 bowel cancer testing service, designed to improve early detection and assess hereditary risk.

Elemental Royalty Poised for Growth in the Mid-Tier Precious Metals Sector, Says Cantor Fitzgerald

Elemental Royalty Corp. receives Buy rating from Cantor Fitzgerald, citing strong growth outlook and robust royalty cash flows.

Cora Gold Funding Boost Fuels Sanankoro’s Push Toward Key Permit Milestone (Video)

Cora Gold CEO Bert Monro outlines how fresh funding will accelerate permitting at the Sanankoro Gold Project in Mali — and why signs from the government are giving the company new momentum heading into 2026

Tekmar Group secures second €8m offshore wind contract

Tekmar Group has been awarded a contract worth more than €8 million to supply its 10th Generation Cable Protection System for a major UK offshore wind farm.

Ilika ships first Stereax M300 prototypes

Ilika has begun shipping prototype Stereax M300 solid state batteries to customers, marking a key commercial milestone for the company.

Thor Energy updates HY-Range exploration and portfolio strategy

Thor Energy has provided an update on exploration planning at its HY-Range hydrogen and helium project in South Australia, including preparations for a major 2D seismic survey in 2026.

    Search

    Search